Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion type Assertion NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_head.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion description "[In this study, we assessed the effect of single nucleotide polymorphisms in genes for interleukin 1 receptor antagonist (IL1RN), interleukin 4 (IL4), interleukin 6 (IL6), interleukin 10 (IL10), interferon (IFNG), tumor necrosis factor (TNF) and the cell surface receptors tumor necrosis factor receptor II (TNFRSFIB), vitamin D receptor (VDR) and estrogen receptor alpha (ESR1) in a homogeneous cohort of 228 HLA identical sibling transplants for chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_provenance.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion evidence source_evidence_literature NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_provenance.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion SIO_000772 20305143 NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_provenance.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion wasDerivedFrom befree-20150227 NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_provenance.
- NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_assertion wasGeneratedBy ECO_0000203 NP497522.RAxIrIRoe2gBuD-mZ0PeQcE_W8gJKia3Lxq-19aCdpj3w130_provenance.